Details
Stereochemistry | ACHIRAL |
Molecular Formula | C8H9NO2 |
Molecular Weight | 151.1626 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)NC1=CC=C(O)C=C1
InChI
InChIKey=RZVAJINKPMORJF-UHFFFAOYSA-N
InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)
Molecular Formula | C8H9NO2 |
Molecular Weight | 151.1626 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:52:43 UTC 2023
by
admin
on
Sat Dec 16 16:52:43 UTC 2023
|
Record UNII |
362O9ITL9D
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
N02AJ17
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
||
|
CFR |
21 CFR 341.40
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
||
|
WHO-VATC |
QN02BE71
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
||
|
NCI_THESAURUS |
C2356
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
7.1
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
||
|
WHO-VATC |
QN02BE01
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
||
|
WHO-ATC |
N02AJ06
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
||
|
CFR |
21 CFR 862.3030
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
||
|
WHO-ATC |
N02BE71
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
||
|
CFR |
21 CFR 310.201
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
||
|
EPA PESTICIDE CODE |
606318
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
||
|
WHO-VATC |
QN02BE51
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
||
|
LOINC |
75071-1
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
||
|
WHO-ATC |
N02BE51
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
||
|
WHO-ATC |
N02BE01
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
||
|
WHO-ATC |
N02AJ13
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
2.1
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
||
|
LIVERTOX |
NBK548162
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
||
|
WHO-ATC |
N02AJ01
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1003009
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
PRIMARY | |||
|
SUB09611MIG
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
PRIMARY | |||
|
DTXSID2020006
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
PRIMARY | |||
|
362O9ITL9D
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
PRIMARY | |||
|
1983
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
PRIMARY | |||
|
DB00316
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
PRIMARY | |||
|
PARACETAMOL
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
PRIMARY | |||
|
8055-08-1
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
SUPERSEDED | |||
|
Acetaminophen
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
PRIMARY | |||
|
m1317
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
PRIMARY | Merck Index | ||
|
ACETAMINOPHEN
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
PRIMARY | Description: A white, crystalline powder; odourless. Solubility: Sparingly soluble in water; freely soluble in ethanol (~750 g/l) TS and acetone R; practically insoluble in ether R. Category: Analgesic; antipyretic. Storage: Paracetamol should be kept in a tightly closed container, protected from light. Definition: Paracetamol contains not less than 98.5% and not more than 101.0% of C8H9NO2, calculated with reference to thedried substance. | ||
|
626
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
PRIMARY | |||
|
109028
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
PRIMARY | |||
|
100000090270
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
PRIMARY | |||
|
203-157-5
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
PRIMARY | |||
|
362O9ITL9D
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
PRIMARY | |||
|
CHEMBL112
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
PRIMARY | |||
|
52
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
PRIMARY | |||
|
161
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
PRIMARY | RxNorm | ||
|
3001
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
PRIMARY | |||
|
46195
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
PRIMARY | |||
|
3991
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
PRIMARY | |||
|
D000082
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
PRIMARY | |||
|
103-90-2
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
PRIMARY | |||
|
5239
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
PRIMARY | |||
|
C198
Created by
admin on Sat Dec 16 16:52:51 UTC 2023 , Edited by admin on Sat Dec 16 16:52:51 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
BINDER->LIGAND |
BINDING
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE |
Enzyme responsible for the bulk of NAPQI formation
MAJOR
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
|
||
|
METABOLITE INACTIVE -> PARENT |
URINE
|
||
|
METABOLITE INACTIVE -> PARENT |
Major metabolite in infants and young children glucuronide is major metabolite in adults.
MAJOR
URINE
|
||
|
METABOLITE INACTIVE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE INACTIVE -> PARENT |
MAJOR
URINE
|
||
|
PARENT -> METABOLITE ACTIVE |
Percent of dose excreted in urine as metabolite.
AMOUNT ADMINISTERED
URINE
|
||
|
METABOLITE ACTIVE -> PARENT |
|
||
|
METABOLITE -> PARENT |
MINOR
PLASMA
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE ACTIVE -> PARENT |
May be substrate for formation of AM-404
MINOR
|
||
|
METABOLITE TOXIC -> PARENT |
Metabolite produced hepatic necrosis in man.
AMOUNT EXCRETED
URINE
|
||
|
PARENT -> METABOLITE ACTIVE |
Percent of dose excreted in urine as metabolite 60-80
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (TLC)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Tmax | PHARMACOKINETIC |
|
|
|||
ORAL BIOAVAILABILITY | PHARMACOKINETIC |
|
|
|||
MAXIMUM TOLERATED DOSE | TOXICITY |
|
IV, LESS THAN 50 Kg |
|||
MAXIMUM TOLERATED DOSE | TOXICITY |
|
|
|||
Tmax | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||
RENAL CLEARANCE | PHARMACOKINETIC |
|
|
|||
MAXIMUM TOLERATED DOSE | TOXICITY |
|
|
|||
MAXIMUM TOLERATED DOSE | TOXICITY |
|
|
|||